Continuous infusion of vancomycin in neonates

被引：26
|
作者：
Patel, Anisa D. [1 ,2 ]
Anand, Dhullipala [1 ]
Lucas, Carol [3 ]
Thomson, Alison H. [4 ,5 ]
机构：
[1] Royal Hosp Sick Children, Neonatal Intens Care Unit, Glasgow G3 8SJ, Lanark, Scotland
[2] Royal Hosp Sick Children, Yorkhill Hosp, Dept Pharm, Glasgow G3 8SJ, Lanark, Scotland
[3] Royal Hosp Sick Children, Dept Clin Microbiol, Glasgow G3 8SJ, Lanark, Scotland
[4] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[5] Western Infirm & Associated Hosp, Dept Pharm, Glasgow, Lanark, Scotland
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2013年 / 98卷 / 06期
关键词：
D O I：
10.1136/archdischild-2012-303197
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [21] Role of fluid status markers as risk factors for suboptimal vancomycin concentration during continuous infusion in neonates: an observational study
    V. L. Cousin
    Q. Laudouar
    N. Le Saché
    M. Mokhtari
    P. Durand
    V. Furlan
    P. Tissières
    European Journal of Pediatrics, 2022, 181 : 2935 - 2942
  • [22] CONTINUOUS INFUSION OF VANCOMYCIN IN SEPTIC PATIENTS ON CONTINUOUS RENAL REPLACEMENT THERAPY
    Covajes, C.
    De Backer, D.
    Ocampos-Martinez, E.
    Penaccini, L.
    Abdelhadi, A.
    Jacobs, F.
    Vincent, J. -L.
    Taccone, F. S.
    INTENSIVE CARE MEDICINE, 2011, 37 : S264 - S264
  • [23] Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented gram positive infections: A new dosage schedule
    Plan, O
    Milesi, C
    Pidoux, O
    Fournier-Favre, S
    Badr, M
    Mazurier, E
    Montoya, F
    Picard, JC
    PEDIATRIC RESEARCH, 2004, 55 (04) : 398A - 398A
  • [24] Role of fluid status markers as risk factors for suboptimal vancomycin concentration during continuous infusion in neonates: an observational study
    Cousin, V. L.
    Laudouar, Q.
    Le Sache, N.
    Mokhtari, M.
    Durand, P.
    Furlan, V
    Tissieres, P.
    EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (08) : 2935 - 2942
  • [25] VANCOMYCIN CONTINUOUS VERSUS INTERMITTENT INFUSION DURING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Lin, Hsin
    Bukovskaya, Yana
    de Moya, Marc
    Schmidt, Ulrich
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [26] Continuous infusion of vancomycin:: Are we using the right dose?
    Conceiçao, MF
    Paiva, JA
    Pereira, JM
    Aguiar, L
    Barbosa, S
    Gomes, JP
    Honrado, T
    Maia, I
    Massada, S
    Rios, M
    Sousa-Dias, C
    Mota, AM
    INTENSIVE CARE MEDICINE, 2001, 27 : S171 - S171
  • [27] NEPHROTOXICITY DURING CONTINUOUS INFUSION OF VANCOMYCIN IN SEPTIC PATIENT
    Cianferroni, S.
    Devigili, A.
    Hougardy, J. -M.
    Penaccini, L.
    Ocampos-Martinez, E.
    Abdelhadii, A.
    Jacobs, F.
    Vincent, J. -L.
    Taccone, F. S.
    INTENSIVE CARE MEDICINE, 2010, 36 : S247 - S247
  • [28] CONTINUOUS-INFUSION OF VANCOMYCIN IN NEWBORN-INFANTS
    BORDERON, JC
    LAUGIER, J
    CHAMBOUX, C
    SALIBA, E
    MATHIEU, A
    PATHOLOGIE BIOLOGIE, 1994, 42 (05): : 525 - 529
  • [29] Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
    Derijks-Engwegen, Judith Y. M. N.
    Jager, Nynke G. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 665 - 669
  • [30] Development of Population pharmacokinetics Model of continuous infusion of Vancomycin
    Ben Romdhane, H.
    Ben Fredj, N.
    Ben Fadhel, N.
    Chadli, Z.
    Chaabane, A.
    Boughattas, N.
    Woillard, J. B.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 87 - 87
12345